US$ 25.45
semaglutide nyc Advertising for Wegovy (semaglutide) and other weight loss injections outside Penn Station in New York on Tuesday, June 25, 2024. (© Richard B. Levine Stock Photo GLP1 weight loss success stories
Description
Individual results vary and no outcome is guaranteed

Current status Retatrutide remains investigational and is not yet approved

However, new data on this subject continue to be released which adds new evidence to the therapeutic scenario

This is just part of the process for some patients

BMI 30 or higher : Eligible based on weight alone